Acrivon Therapeutics所有资讯

Acrivon Therapeutics | S-3：特定交易注册声明

04/18 04:41

Acrivon Therapeutics | 4：持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.

04/16 04:20

Acrivon Therapeutics | 4：持股变动声明-股东 PERCEPTIVE ADVISORS LLC

04/15 20:58

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%)等

04/15 20:23

Acrivon Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%)等

04/12 04:22

Acrivon Therapeutics | 8-K：重大事件

04/09 19:09

Acrivon Therapeutics | S-8：员工福利计划证券登记

03/29 21:07

Acrivon Therapeutics | 8-K：Acrivon Therapeutics公布2023年第四季度和全年财务业绩和业务亮点

03/28 20:04

Acrivon Therapeutics | 10-K：年度报表

03/28 19:39

Acrivon Therapeutics | 4：持股变动声明-董事 Palani Santhosh

03/07 05:36

Acrivon Therapeutics | 3：首次持股声明-董事 Palani Santhosh

03/07 05:31

Acrivon Therapeutics | 8-K：重大事件

03/04 21:20

Acrivon Therapeutics | 4：持股变动声明-高管 Masson Kristina

02/17 06:19

Acrivon Therapeutics | 4：持股变动声明-高管 Miller Mary

02/17 06:18

Acrivon Therapeutics | 4：持股变动声明-高管 Holm-Jorgensen Rasmus

02/17 06:17

Acrivon Therapeutics | 4：持股变动声明-高管 Devroe Eric

02/17 06:13

Acrivon Therapeutics | 4：持股变动声明-高管 Gamelin Erick

02/17 06:13

Acrivon Therapeutics | 4：持股变动声明-高管 Blume-Jensen Peter

02/17 06:08

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(13.6%),Joseph Edelman(13.6%)等

02/15 06:37

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Citadel Advisors LLC(7.4%),Citadel Advisors Holdings LP(7.4%)等

02/15 06:02